Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART long-term follow-up study of donor-specific HLA antibodies after kidney transplantation
2013-004956-39Phase 4Completed
- Sponsor
- LMU Klinikum
- Start
- May 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus and cyclosporine in kidney transplant (2 arms), sponsored by LMU Klinikum. Primary endpoint: Incidence of de novo donor-specific antibodies at current visit. Started May 2014; status: completed.
02
Drugs
sirolimuscyclosporine
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2013-004956-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004956-39.